Affinity Chromatography Market Size, Share and Trends 2026 to 2035

Revenue, 2025

USD 3.90 Bn

Forecast Year, 2035

USD 8.98 Bn

CAGR, 2026 - 2035

8.70%

Report Coverage

Global

What is the Affinity Chromatography Market Size in 2026?

The global affinity chromatography market size accounted for USD 3.90 billion in 2025 and is predicted to increase from USD 4.24 billion in 2026 to approximately USD 8.98 billion by 2035, expanding at a CAGR of 8.70% from 2026 to 2035. The market is rapidly expanding due to the massive investment in R&D for drug development to combat rising chronic diseases and increasing demand for highly efficient, scalable, and specific protein purification methods.

Key Takeaways

• North America held the largest market share of 38% in 2025.
• The Asia Pacific is projected to grow at the fastest CAGR during the foreseeable period.
• By product, the resins segment dominated the market with a 58% share in 2025.
• By product, the columns segment is the second-largest shareholder and is expected to grow at a significant rate between 2026 and 2035.
• By technique, the protein A affinity chromatography segment dominated the market with a 48% share in 2025.
• By technique, the IMAC segment is the second-largest shareholder and is expected to grow at a significant rate between 2026 and 2035.
• By application, the antibody purification segment dominated the market with a maximum share in 2025.
• By application, the vaccine production segment is the second-largest shareholder and is expected to grow at the fastest rate between 2026 and 2035.
• By end user, the pharmaceutical & biotechnology companies segment dominated the market with a 60% share in 2025.
• By end user, the academic & research institutes segment is the second-largest shareholder and is expected to grow at a significant rate between 2026 and 2035.

Market Overview

The affinity chromatography technique is a specific method used to purify biomolecules like proteins, nucleic acids, or antigens from complex mixtures based on reversible and specific biological interactions. The affinity chromatography market encompasses the development and distribution of instruments, consumables like resins, columns, and reagents, and services designed to purify specific biomolecules like antibodies and proteins by interfering with their high-affinity binding to immobilized ligands. It is a highly crucial aspect in the research industry, pharmaceuticals , and diagnostics, especially in bioprocessing, where it assists in developing high-purity products. The market is largely driven by increasing research and development in biotechnology , the expanding biopharmaceutical sector, and the rising adoption of monoclonal antibody therapies.

Affinity Chromatography Market Trends

• There is a rising demand for protein A/G/L affinity chromatography and immobilized metal affinity chromatography (IMAC). These methods are largely used in rapid diagnostic test strips beyond just drug manufacturing.
• The increasing production of monoclonal antibodies , vaccines, and recombinant proteins boosts the demand for affinity chromatography that offers the high specificity needed to separate these complex biomolecules.
• Technological advancements in ligands and resins are another trend that is shaping the market by enhancing binding capacity and process efficiency, allowing faster and more cost-effective downstream purification.
• There is a rapid shift toward disposable affinity chromatography columns and systems to eliminate cross-contamination and cleaning validation time.
• The rising development of sophisticated healthcare infrastructure in emerging regions and massive investment in biotechnology research are creating a substantial opportunity in the market.

Market Scope

Market Dynamics

Drivers

Growing Demand for Biopharmaceuticals and Antibodies

The market is largely driven by the increasing production and demand for biologics and vaccines amid rising chronic diseases and an aging population. Monoclonal antibodies and recombinant proteins capture nearly 60% of the current pipelines of therapeutics. The increasing use of affinity chromatography in vaccine manufacturing is further creating a rapid demand for highly scalable, cost-effective, and purification technologies.

Restraint

Regulatory Barriers with Process Complexity

Despite its advantages, affinity chromatography faces several barriers to large-scale adoption. The technique requires a highly skilled workforce, and some purification steps are labor-intensive and complex. Additionally, the process must comply with stringent regulatory standards for purity and safety set by authorities such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Lengthy validation procedures further create bottlenecks that may limit market growth.

Opportunity

Adoption of Automation Technologies

The industry is rapidly adopting automation technologies to increase productivity, minimize cleaning validation, and reduce cross-contamination in GMP environments. Automated platforms, such as protein A units, reduce manual steps while improving reproducibility, boosting process efficiency and yield. Additionally, the expansion of biopharmaceutical manufacturing presents significant growth opportunities for the market.

Segment Insights

Product Insights

Affinity Chromatography Market Share, By Product, 2025-2035 (%)

The Resins Segment Held the Largest Market Share of 58% in 2025

The resins segment dominated the affinity chromatography market with the largest share of 58% in 2025 due to their capabilities like high specificity, exceptional binding capacity, and higher scalability in the purification of complex biopharmaceuticals, especially for monoclonal antibodies. Resin-based affinity chromatography utilizes natural polymers like agarose for downstream processing, supporting the segments' growth. The segment's dominance is also driven by the high usage of resins in biopharmaceutical purification and increasing biologics production.

The columns segment is the second-largest shareholder, holding a 22% share in 2025, and is expected to grow at a significant rate between 2026 and 2035. This is due to their offerings, such as reproducibility and automation potential, which are essential for large-scale biopharmaceutical manufacturing. Columns offer high flow rates and low back pressure, which are crucial factors for processing large volumes of complex biological materials. The increasing demand for efficient separation systems and their widespread usage in laboratories further support segmental growth.

The kits & reagents segment held a 20% share of the market in 2025 and is expected to grow at the fastest rate over the forecast period, as they are crucial in biopharmaceutical production, drug discovery, and research. The segment's growth is mainly driven by the increasing demand for high-purity, specific, and reproducible outcomes in antibody and protein purification. The rising adoption of ready-to-use solutions and increasing research activities are expected to boost the need for kits and reagents.

Application Insights

The Antibody Purification Segment Held the Highest Market Share in 2025

The antibody purification segment dominated the affinity chromatography market with the maximum share in 2025 due to the increasing demand for high-purity monoclonal antibodies in therapeutics, diagnostics, and research, along with efficient affinity techniques like protein A chromatography. Antibody purification provides a single-step high selectivity and purity for monoclonal antibodies. Affinity chromatography isolates the targeted antibody from complex mixtures like cell culture supernates and serum in a single step.

The vaccine production segment is expected to grow at the fastest rate between 2026 and 2035. This is because it requires an extreme level of purity, highly efficient processing for complex products, and the capability to scale up rapidly during outbreaks of infectious diseases. Affinity chromatography often achieves the required high purity of vaccine antigens, virus-like particles, and viral vectors in a single step.

The monoclonal antibodies segment held a significant share of the market in 2025. This is due to the heightened demand for high-purity therapeutic proteins, the excellent efficacy of protein A-based purification, and the crucial role of these antibodies in treating diseases like cancer and autoimmune disorders.

The protein purification segment held a considerable share of the market in 2025. The segment's growth is attributed to the efficiency of affinity chromatography that enables high recovery of active proteins from complex, dilute cell lysates, which is critical in early-stage research and drug discovery .

Technique Insights

The Protein ‘A' Affinity Chromatography Segment Held the Largest Market Share of 48% in 2025

The protein ‘A' affinity chromatography segment dominated the affinity chromatography market with a share of 48% in 2025, as it is considered an industry standard to capture monoclonal antibodies and FC-fusion proteins. The segment's dominance is also driven by its high specificity, purity, and capacity in a single step that allows faster and highly standardized industrial production. This technique can achieve over 95% of purity in a single step from dirty feedstocks or complex molecules. This technique is widely used in antibody purification.

The IMAC segment is the second-largest shareholder, holding about 22% share in 2025, and is expected to grow at a significant rate between 2026 and 2035. This is due to its exceptional versatility, cost-efficiency, and capability to develop high-purity recombinant proteins in a single step. The IMAC technique can purify native proteins that lack a tag but are exposed to residues that can interact with metal ions. The increasing use of this technique in recombinant protein purification and metal-binding proteins supports segmental growth.

Affinity Chromatography Market Share, By Technique, 2025-2035 (%)

The dye-ligand chromatography segment held a significant market share of 15% in 2025. This is because it provides a highly cost-effective, stable, and scalable option to conventional biological affinity ligands like antibodies or enzymes. The technique enables selective and broad-spectrum purification of proteins and enzymes while bypassing high costs.

The immunoaffinity chromatography segment held a notable market share in 2025. This is because this technique offers unmatched specificity that allows purification of complex biomolecules to near-homogeneity, often more than 95% purity in a single step. The segment is growing due to the increasing production of monoclonal antibodies and recombinant proteins, where immunoaffinity works as a scalable and highly efficient capture step.

End User Insights

Affinity Chromatography Market Share, By End User, 2025-2035 (%)

Pharmaceutical & Biotechnology Companies Held the Highest Market Share of 60% in 2025

The pharmaceutical & biotechnology companies segment dominated the affinity chromatography market with a share of 60% in 2025. This is because affinity chromatography is considered an industry-standard to purify complex biologics like vaccines and recombinant proteins. The increasing focus on companies which developing personalized medicine and targeted therapies like antibody-drug conjugates and gene therapies drives the segment's dominance . Their high investments in R&D and high production of biologics also boosted the segmental growth.

The academic & research institutes segment is the second-largest shareholder, holding a 25% share in 2025, and is expected to grow at a significant rate between 2026 and 2035. This is due to their ongoing research activities, which boost the demand for affinity chromatography, as it is important to achieve high-level purification of proteins for drug discovery applications. The segment's growth is also driven by the increasing study of proteins and genomics, where high-resolution separation methods are essential.

The contract research organizations (CROs) segment held a 15% share of the market in 2025 and is expected to grow at the fastest rate in the coming years. This is due to the industry-wide shift to outsourcing drug development, the high technical expertise needed for purification, and demand for cost-efficient scalability. CROs can handle high-throughput operations and scale up production from pre-clinical to commercial level.

Regional Insights

North America Affinity Chromatography Market Size and Growth 2026 to 2035

The North America affinity chromatography market size is estimated at USD 1.48 billion in 2025 and is projected to reach approximately USD 3.46 billion by 2035, with a 8.86% CAGR from 2026 to 2035.

North America Held a Major Market Share of 38% in 2025

North America dominated the affinity chromatography market with a major share of 38% in 2025. This is primarily due to its advanced biopharmaceutical infrastructure, high R&D investments, and strict regulatory requirements for high-purity biologics. The region is considered a hub for leading pharmaceutical manufacturers, CROs/CMOs, and biotech firms that totally depend on affinity chromatography to purify complex biologics like monoclonal antibodies and vaccines.

The region is home to various leading academic and research institutes, contract research organizations, and biotech companies that heavily invest in drug discovery and process development. Also, the laboratories in North America have a strong culture of early adoption of advanced analytical and separation technologies like single-use chromatography systems and automated platforms.

U.S. Affinity Chromatography Market Size and Growth 2026 to 2035

The U.S. affinity chromatography market size is calculated at USD 1.11 billion in 2025 and is expected to reach nearly USD 2.61 billion in 2035, accelerating at a strong CAGR of 8.93% between 2026 and 2035.

U.S. Affinity Chromatography Market Analysis

The U.S. is a major contributor to the market, driven by its leadership in the biopharmaceutical industry, substantial R&D investments, and stringent regulatory standards for product purity. Leading U.S. companies are developing high-affinity ligands, novel stationary phases, and advanced matrices such as agarose and silica to enhance specificity and binding capacity. The biopharmaceutical industry in the U.S. is increasingly adopting continuous and intensified bioprocessing, creating demand for advanced affinity products optimized for higher throughput and reuse.

Asia Pacific: The Fastest-Growing Region

Asia Pacific is expected to grow at the fastest rate in the market during the forecast period, driven by the expansion of biopharmaceutical manufacturing and advancements in purification technologies. The increasing presence of contract development and manufacturing organizations (CDMOs) in key economies is fueling demand for advanced purification methods. Initiatives such as India's Make in India program and China's 14th Five-Year Plan for biotechnology are supporting local biopharma R&D and production. Furthermore, the emergence of next-generation, high-efficiency purification techniques to replace conventional methods is significantly boosting market growth in the region.

China Affinity Chromatography Market Analysis

The market in China is growing due to the rapid expansion of the biopharmaceutical sector, significant government investment in biotechnology infrastructure, and a strategic push toward domestic production of advanced medicines. Affinity chromatography remains a standard method for biologic purification. Policies such as China's 14th Five-Year Plan and related industrial initiatives are strongly supporting market growth. Additionally, China's position as a global hub for contract manufacturing, with advanced high-end production capabilities, further fuels the market expansion.

Europe: The Second-Largest Market

Europe held a 29% share of the affinity chromatography market in 2025 and is expected to grow at a significant rate in the upcoming period. The region's expansion is driven by a highly advanced pharmaceutical and biopharmaceutical sector, stringent environmental and safety regulations, and initiatives to reduce carbon emissions. Europe is a global hub for the production of monoclonal antibodies, vaccines, recombinant proteins, and biosimilars, which drives demand for advanced purification technologies. Regulatory bodies such as the European Medicines Agency enforce high safety and quality standards, further supporting market growth.

Germany Affinity Chromatography Market Analysis

Germany holds the largest share of the European affinity chromatography market, driven by its strong pharmaceutical and biotech manufacturing capabilities. The country's advanced research infrastructure and the active presence of global market players further support growth. High demand for biologics, fueled by the rising prevalence of chronic diseases such as cancer and cardiovascular diseases, is a key growth driver. Additionally, the increasing number of biotech startups adopting advanced affinity chromatography techniques is significantly contributing to market expansion.

Affinity Chromatography Market Companies

• Cytiva (Danaher Corporation)
• Merck KGaA
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories, Inc.
• Sartorius AG
• Tosoh Corporation
• Purolite Corporation (Ecolab)
• Repligen Corporation
• Agilent Technologies, Inc.
• PerkinElmer, Inc.
• Kaneka Corporation
• GE Healthcare (Cytiva)
• Shimadzu Corporation
• Avantor, Inc.
• Pall Corporation

Segments Covered in the Report

By Product

• Resins
  
  • Protein A Resins
  • Protein G Resin
  • Immobilized Metal Affinity Chromatography (IMAC) Resins
  • Dye Ligand Resins
• Columns
  
  • Prepacked Columns
  • Empty Columns
• Kits & Reagent
  
  • Buffers
  • Elution Reagents
  • Purification Kits

By Application

• Antibody Purification
  
  • Monoclonal Antibodie
  • Polyclonal Antibodies
• Protein Purification
  
  • Recombinant Proteins
  • Enzyme
• Vaccine Production
• Others
  
  • Biomarker Discovery
  • Diagnostics

By End User

• Pharmaceutical & Biotechnology Companies
  
  • Biopharmaceutical Manufacturers
  • Vaccine Manufacturers
• Academic & Research Institutes
  
  • Universities
  • Research Labs
• Contract Research Organization

By Technique

• Protein A Affinity Chromatography
• Immobilized Metal Affinity Chromatography (IMAC)
• Dye-Ligand Chromatography
• Others
  
  • Lectin Affinity Chromatography
  • Immunoaffinity Chromatography

By Region

• North America
• Latin America
• Europe
• Asia-pacific
• Middle and East Africa